Answers are grounded in this paper and cite their sources.
Genome assembly improves chromosome structure in Meyerozyma guilliermondii, suggesting enhanced bioprocessing capabilities.
Meyerozyma guilliermondii, a haploid yeast (phylum Ascomycota), is useful in bioprocessing and bioremediation and is an infrequent pathogen of humans. The availability of highly accurate, long-read DNA sequencing methods provided the opportunity to improve the M. guilliermondii genome assembly. Using PacBio HiFi technology, we generated a chromosome-level, telomere-to-telomere assembly for the M. guilliermondii type strain ATCC 6260. This assembly closed gaps in the current reference sequence and resolved a translocation artifact that affected the size and structure of chromosomes 4 and 5. The improved genome sequence is available publicly and will facilitate future study of this species.
No takes yet. Share an insight, caveat, or question.
Hoyer et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: